Latest News on Ranbaxy Laboratories
Showing of 0 - 10 from 65 results
Ranbaxy Laboratories - Total results - 65
Apr 11, 2019
Sun Pharma's senior executive, wife settle insider trading case with SEBISun Pharma group's senior executive Abhay Arvind Gandhi and his wife Kiran have settled with SEBI a case related to insider trading in shares of Ranbaxy Laboratories in 2014
Feb 18, 2019
Malvinder Singh files criminal complaint against brother Shivinder Singh, spiritual leader for financial fraud, death threatThe relationship between the Singh brothers, erstwhile promoters of Fortis Healthcare, went sour after allegations of fund diversion from the healthcare chain emerged.
Dec 21, 2018
Religare approaches Corporate Ministry with complaint against Singh brothers, ex-chairman Sunil GodhwaniEarlier on Wednesday, Religare Finvest lodged a criminal complaint with the Economic Offences Wing (EOW) of the Delhi Police against the Singh brothers.
Sep 06, 2018
Malvinder Singh asked to deposit 3.5 mn Singapore dollars, 'disobeyed orders' says Delhi HCThe court’s order came after it was informed by the counsel for Malvinder, who was present in the court, that his 45 lakh equity shares in Religare Healthcare Pvt Ltd were sold in Singapore in April.
Sep 05, 2018
Fortis Healthcare: Shivinder Singh sues brother Malvinder alleging oppression, mismanagement of business; moves NCLTLast month, the brothers who are co-promoters of the Group had put the blame on former Religare Enterprises Chairman and Managing Director Sunil Godhwani for the group's troubles.
Mar 28, 2018
Fortis Healthcare board approves demerger, to sell hospital business to Manipal, TPG CapitalManipal Hospitals, part of Manipal Education and Medical Group (MEMG), is owned by Dr Ranjan Pai and has been backed by TPG, a leading global alternative asset firm and experienced healthcare investor since 2015.
Feb 09, 2018
Fortis vs Daiichi Sankyo: Singh brothers resign after Delhi HC upholds Rs 3,500 cr arbitral award to Japanese pharmaA tribunal in Singapore had passed the verdict in favour of Daiichi holding that the former Ranbaxy promoters had concealed certain information
Aug 11, 2015
Sun Pharma Q1 net profit down by 60% over integration woesTotal income of the company increased however to Rs 6,767.58 crore during the first quarter of 2015-16 as against Rs 6,341.21 crore for the year ago period.
May 29, 2015
Sun Pharma reports Q4 net profit at Rs 888 cr, Ranbaxy deal shrinks earningsNet sales of the company stood at Rs 27,286.50 crore for the year ended March 31. The same stood at Rs 16,004.39 crore in the last year.
Apr 22, 2015
Daiichi Sankyo's misery ends, block deal to give company coup de grâceEven after allowing for control premium, the price that Daiichi Sankyo paid for Ranbaxy Laboratories was clearly excessive, and those in the know said sagely that winner’s curse would have its say sooner than later.